Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




No Added Risk During Ventilation for Pregnant Patients

By HospiMedica International staff writers
Posted on 16 Oct 2018
A new study shows that maternal mortality in obstetric patients, as related to mechanical ventilation, has the same associated factors as in the non-obstetric population.

Researchers at the University of Cartagena (Colombia), Brown University (Providence, RI, USA), and other institutions conducted a retrospective observational study that included 2,116 obstetric patients (median age 26) in six hospitals in Colombia to identify risk factors of maternal mortality in mechanically ventilated patients. More...
The study cohort included patients admitted to the intensive care unit (ICU), and who required mechanical ventilation for more than 24 hours. Discrimination analysis was conducted continuously on clinical and laboratory variables for their ability to predict mortality.

The results revealed that 299 (14%) of the pregnant women within the study suffered acute respiratory failure and required mechanical ventilation. Obstetric hemorrhage, hypertensive disorders of pregnancy, and maternal sepsis were the most common indications for mechanical ventilation. Factors identified as related to higher mortality included use of a vasopressor, blood transfusions, neurological dysfunction, coagulopathy, and acute respiratory distress syndrome (ARDS). The study was presented at the CHEST annual meeting, held during October 2018, in San Antonio (TX, USA).

“The results show that ARDS, the presence of coagulopathy, and neurological dysfunction are clinical factors associated with mortality,” said study presenter and co-author Jose Antonio Rojas-Suarez, MD, MSc, of the University of Cartagena. “Nulliparity was associated with a lower risk of death. Clinical variables that showed an acceptable discrimination capacity as predictors of mortality were mean blood pressure and pH.”

Causes of ARDS related to pregnancy include epidural blocks, amniotic fluid embolism, preeclampsia, septic abortion, and retained products of conception that can include aspiration pneumonitis, influenza pneumonia, blood transfusions, sepsis, and trauma. ARDS in pregnancy also poses its own set of unique challenges, as two circulatory systems are being ventilated using only one set of diseased lungs. Despite extensive research to improve the management of ARDS, mortality remains high, and few strategies have shown a mortality benefit.

Related Links:
University of Cartagena
Brown University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.